Independent fund research. Built on SEC filings.

How we research funds

ETF · Leveraged & Inverse · Direxion

LABD Holdings: What Direxion Daily S&P Biotech Bear 3X ETF Owns

Ticker LABD · Index fund · · Holdings as of Jul 31, 2026

Expense ratio
1.07%$107/yr per $10k
5-yr return
−37.7%annualized
1-yr return
−70.0%as of Dec 2025
Net assets
$54.2Mall share classes
Holdings
10

Bottom line

What does LABD hold?

LABD held 10 positions as of Jul 31, 2026. Its largest holding is Goldman Financial at 52.74% of the fund, and the top 10 positions add up to 125%. By asset type it is 138% cash & short-term funds.

Updated Sep 28, 2026

LABD top 10 holdings

#HoldingType% of fundValue
1 Goldman Financial
GOLDMAN FINL SQ TRSRY INST 506
Cash & short-term funds 52.74%$28.6M
2 Dreyfus
DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208…
Cash & short-term funds 40.47%$21.9M
3 Goldman Sachs Liq Es Fd A
GOLDMAN SACHS FIN GOV 465 INSTITUT
Cash & short-term funds 26.30%$14.3M
4 Dreyfus
DREYFUS TRSRY SECURITIES CASH MGMT
Cash & short-term funds 18.03%$9.8M
5 N/a
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
DO 2.98%$1.6M
6 N/a
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
DO 1.43%$772.9K
7 N/a
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
DO -1.55%$-842.2K
8 N/a
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
DO -4.11%$-2.2M
9 N/a
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
DO -4.88%$-2.6M
10 N/a
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
DO -6.37%$-3.5M

Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 28, 2026

Asset mix

Cash & short-term funds137.5%